Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
McKesson
Julphar
Johnson and Johnson
Cantor Fitzgerald
Boehringer Ingelheim
Argus Health
Daiichi Sankyo
Chinese Patent Office
Colorcon

Generated: October 17, 2017

DrugPatentWatch Database Preview

Fluvoxamine maleate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for fluvoxamine maleate and what is the scope of fluvoxamine maleate freedom to operate?

Fluvoxamine maleate
is the generic ingredient in three branded drugs marketed by Eci Pharms Llc, Actavis Elizabeth, Apotex, Ani Pharms, Sun Pharm Inds, Jazz Pharms, Torrent Pharms Ltd, Solvay, Mylan, Anchen Pharms, Upsher-smith Labs, Teva, Watson Labs, Ani Pharms Inc, and Synthon Pharms, and is included in nineteen NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Fluvoxamine maleate has twenty-four patent family members in eighteen countries.

There are eleven drug master file entries for fluvoxamine maleate. Sixteen suppliers are listed for this compound.

Summary for Generic Name: fluvoxamine maleate

US Patents:1
Tradenames:3
Applicants:15
NDAs:19
Drug Master File Entries: see list11
Suppliers / Packagers: see list16
Bulk Api Vendors: see list80
Clinical Trials: see list225
Patent Applications: see list6,637
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:fluvoxamine maleate at DailyMed

Pharmacology for Ingredient: fluvoxamine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds
FLUVOXAMINE MALEATE
fluvoxamine maleate
TABLET;ORAL076125-001Apr 29, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Eci Pharms Llc
FLUVOXAMINE MALEATE
fluvoxamine maleate
TABLET;ORAL075900-003Feb 23, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Torrent Pharms Ltd
FLUVOXAMINE MALEATE
fluvoxamine maleate
CAPSULE, EXTENDED RELEASE;ORAL203240-002Oct 31, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
FLUVOXAMINE MALEATE
fluvoxamine maleate
TABLET;ORAL075894-002Apr 18, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
FLUVOXAMINE MALEATE
fluvoxamine maleate
TABLET;ORAL075893-003Sep 10, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Synthon Pharms
FLUVOXAMINE MALEATE
fluvoxamine maleate
TABLET;ORAL075899-002Jan 17, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Eci Pharms Llc
FLUVOXAMINE MALEATE
fluvoxamine maleate
TABLET;ORAL075900-002Feb 23, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
FLUVOXAMINE MALEATE
fluvoxamine maleate
TABLET;ORAL075950-001Oct 15, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Solvay
LUVOX
fluvoxamine maleate
TABLET;ORAL020243-004Dec 5, 1994DISCNYesNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
FLUVOXAMINE MALEATE
fluvoxamine maleate
TABLET;ORAL075897-002Jan 25, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: fluvoxamine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Solvay
LUVOX
fluvoxamine maleate
TABLET;ORAL020243-001Dec 5, 1994► Subscribe► Subscribe
Solvay
LUVOX
fluvoxamine maleate
TABLET;ORAL020243-003Dec 5, 1994► Subscribe► Subscribe
Solvay
LUVOX
fluvoxamine maleate
TABLET;ORAL020243-004Dec 5, 1994► Subscribe► Subscribe
Solvay
LUVOX
fluvoxamine maleate
TABLET;ORAL020243-002Dec 5, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: fluvoxamine maleate

Country Document Number Estimated Expiration
Algeria3256► Subscribe
Australia782059► Subscribe
Australia4426700► Subscribe
Russian Federation2275191► Subscribe
Portugal1178780► Subscribe
Cyprus1107750► Subscribe
Slovakia18962001► Subscribe
Canada2698347► Subscribe
Czech Republic20014618► Subscribe
World Intellectual Property Organization (WIPO)0071099► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Chubb
Moodys
Cantor Fitzgerald
Citi
Argus Health
Baxter
US Army
Fuji
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot